| Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients (NCT05252078) | Jiangxi Provincial Cancer Hospital | 2022-06-02 |
| Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma (NCT05845632) | Maastricht University Medical Center | 2022-01-01 |
| JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC (NCT04892173) | Johnson & Johnson Enterprise Innovation Inc. | 2021-12-10 |
| TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY (NCT04481256) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2020-11-11 |
| Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors (NCT04429542) | Bicara Therapeutics | 2020-06-01 |
| Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT04099290) | UNC Lineberger Comprehensive Cancer Center | 2020-01-14 |
| GDF15 Based TPF Induction Chemotherapy for OSCC Patients (NCT02285530) | Shanghai Jiao Tong University School of Medicine | 2019-12-01 |
| A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer (NCT03906526) | Celgene | 2019-07-03 |
| Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630) (NCT03833167) | Merck Sharp & Dohme LLC | 2019-04-01 |
| Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma (NCT04124198) | Christian von Buchwald | 2019-03-01 |
| Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial (NCT03769285) | Women's College Hospital | 2018-12-03 |
| Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC (NCT03370406) | Melissa Pugliano-Mauro | 2018-08-03 |
| Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma (NCT03336606) | Providence Health & Services | 2018-07-25 |
| Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma (NCT03174275) | UNC Lineberger Comprehensive Cancer Center | 2017-12-19 |
| EPR Tumor Oximetry With CE India Ink (NCT03321903) | Philip Schaner | 2017-08-30 |
| Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers (NCT02994069) | Susanne Arnold | 2017-04-11 |
| Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin (NCT02883556) | Assistance Publique - Hôpitaux de Paris | 2017-03-27 |
| The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell Carcinoma (NCT02916368) | Beijing Tongren Hospital | 2017-01-01 |
| Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage (NCT02290145) | Shanghai Jiao Tong University School of Medicine | 2016-12-01 |
| A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients (NCT02285543) | Shanghai Jiao Tong University School of Medicine | 2016-12-01 |
| P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC (NCT03077243) | UNC Lineberger Comprehensive Cancer Center | 2016-12-01 |
| Optical Imaging for Preoperative Delineation of Nonmelanoma Skin Cancers (NCT02666833) | Massachusetts General Hospital | 2016-06-01 |
| Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation Toxicity (NCT02442375) | Radboud University Medical Center | 2016-06-01 |
| Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients (NCT02526953) | Blokhin's Russian Cancer Research Center | 2016-01-01 |
| National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer (NCT02664935) | University of Birmingham | 2015-05-13 |
| Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck (NCT02438995) | Northwell Health | 2015-05-01 |
| Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma (NCT02549638) | Mayo Clinic | 2015-04-08 |
| Safety Study of SEA-CD40 in Cancer Patients (NCT02376699) | Seagen Inc. | 2015-02-28 |
| Neck Dissection Via a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynx (NCT02269020) | Centre Hospitalier Universitaire de Nīmes | 2015-02-16 |
| Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma (NCT02218164) | H. Lee Moffitt Cancer Center and Research Institute | 2014-08-12 |
| De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study (NCT02281955) | UNC Lineberger Comprehensive Cancer Center | 2014-08-01 |
| Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer (NCT02107235) | Traws Pharma, Inc. | 2014-01-01 |
| Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC) (NCT02045186) | UNC Lineberger Comprehensive Cancer Center | 2013-12-01 |
| STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVE (NCT02328391) | Grupo Gallego de Cancer de Pulmon | 2013-09-01 |
| Spanish Registry of Mohs Surgery (NCT02310503) | Fundación Academia Española de Dermatología | 2013-07-01 |
| Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis (NCT01728233) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-06-15 |
| Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer (NCT01494415) | First People's Hospital of Hangzhou | 2012-07-01 |
| De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca (NCT01530997) | UNC Lineberger Comprehensive Cancer Center | 2012-02-07 |
| LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy (NCT01345682) | Boehringer Ingelheim | 2012-01-05 |
| Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea Polyphenols (NCT01496521) | Beijing Friendship Hospital | 2012-01-01 |
| Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC) (NCT01129154) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2010-08-01 |
| Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma (NCT01195922) | National Institute of Dental and Craniofacial Research (NIDCR) | 2010-08-01 |
| Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers (NCT01104714) | Centre Hospitalier Universitaire de Nīmes | 2010-04-01 |
| An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (NCT01142869) | Merck KGaA, Darmstadt, Germany | 2009-12-31 |
| Detecting Lesions in the Oral Cavity With Thermal Imaging (NCT00868725) | Sheba Medical Center | 2009-04-01 |
| Postoperative Concurrent Chemoradiation for Head and Neck Cancer With Multiple Minor Risk (NCT00937612) | Chang Gung Memorial Hospital | 2008-06-01 |
| Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer (NCT00671437) | Washington University School of Medicine | 2008-06-01 |
| Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer (NCT00673049) | Pfizer | 2008-05-01 |
| Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology (NCT00596830) | Pfizer | 2008-04-01 |
| Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) (NCT00632203) | Merck Sharp & Dohme LLC | 2008-03-04 |
| A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer (NCT00660218) | State University of New York - Upstate Medical University | 2008-03-01 |
| Phase II AK Study in Organ Transplant Patients (NCT00829192) | Clinuvel Pharmaceuticals Limited | 2007-11-01 |
| Randomized Multicenter Study of 5 vs 6 Weekly Fraction of RT in the Treatment of SCC of the Head and Neck (NCT00534950) | King Faisal Specialist Hospital & Research Center | 2007-09-01 |
| Analysis of Melanocytes (Pigment Cells) in Sun-Exposed Skin (NCT00875381) | Mayo Clinic | 2007-09-01 |
| BIBW 2992 (Afatinib) in Head & Neck Cancer (NCT00514943) | Boehringer Ingelheim | 2007-08-01 |
| Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to Treat Squamous Cell Carcinoma of the Head and Neck (NCT00474825) | National Baromedical Services | 2007-07-01 |
| Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy (NCT00490061) | Quynh-Thu Le | 2007-07-01 |
| Acitretin Plasma Levels Under Hemodialysis (NCT00488384) | Günther Hofbauer | 2007-06-01 |
| Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer (NCT00448240) | Henry Ford Health System | 2007-02-01 |
| Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia (NCT01362127) | Karolinska University Hospital | 2006-10-01 |
| A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck (NCT00358930) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2006-07-01 |
| Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer (NCT00368329) | Stanford University | 2006-06-01 |
| Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ (NCT00329121) | Peplin | 2006-05-01 |
| Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer (NCT00272181) | Sesen Bio, Inc. | 2006-01-01 |
| Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer (NCT00412776) | Sesen Bio, Inc. | 2005-12-01 |
| Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR (NCT00240682) | Centre Hospitalier of Chartres | 2005-10-01 |
| A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers (NCT00122239) | AHS Cancer Control Alberta | 2005-01-01 |
| Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530) (NCT00073450) | Merck Sharp & Dohme LLC | 2003-09-01 |
| Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck (NCT00233636) | AstraZeneca | 2003-07-01 |
| Post-Operative Drainage Following Lymph Node Dissection (NCT00324272) | Oxford University Hospitals NHS Trust | 2003-01-01 |
| Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation (NCT00313027) | Stanford University | 2002-11-01 |
| TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN (NCT00539630) | Sanofi | 2002-11-01 |
| Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck (NCT00185835) | Stanford University | 2002-06-01 |
| Docetaxel in Non Small Cell Lung Cancer (NSCLC) (NCT00432315) | Sanofi | 2001-05-01 |
| Patient Evaluation for Head and Neck Surgery Branch Studies (NCT00011492) | National Institute on Deafness and Other Communication Disorders (NIDCD) | 2001-03-12 |
| A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma (NCT00190554) | Japan Clinical Oncology Group | 2000-05-01 |
| Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0) (NCT00563862) | Hospital Authority, Hong Kong | 1999-07-01 |
| A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer (NCT00038584) | M.D. Anderson Cancer Center | 1999-06-01 |
| Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0) (NCT00563927) | Hospital Authority, Hong Kong | 1999-03-01 |
| Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT) (NCT00188318) | University Health Network, Toronto | 1998-06-01 |
| Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer (NCT00007631) | US Department of Veterans Affairs | 1998-03-01 |
| Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate (NCT00041613) | Introgen Therapeutics | |
| Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone (NCT00041626) | Introgen Therapeutics | |
| Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck (NCT01491139) | University College, London | |